Contact
Please use this form to send email to PR contact of this press release:
Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
TO:
Please use this form to send email to PR contact of this press release:
Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
TO: